Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : YEEHAW CANDIDATES -- Ignore unavailable to you. Want to Upgrade?

To: Crossy who wrote (822)	1/2/2003 6:28:56 PM
From: JoeinIowa	Read Replies (1) \| Respond to of 23958

Crossy, You sure know how to find them. ALU is a very interesting case. The insurance settlement if it does not come in would be a back breaker. Assuming it does come in this quarter has basically been wiped up out in terms of sales and it is I think their biggest quarter. So this quarter looks bad but it all depends on the insurance payout. Its a very interesting play. Potential is at least 7-10 if it all works out. Were you the one looking at NXB.to with me a while back? They were on the national news with the number one most interesting discovery for 2002. Of course the stock has not done well but I like to keep my eye on strange companies. By the way your IPSU play is looking sweet. LOL. Joe

To: Crossy who wrote (822)	1/2/2003 7:20:14 PM
From: Sergio H	Read Replies (1) \| Respond to of 23958

Thanks Crossy. ALU added to the folio. A few notes on CLGY: Today's volume, even after announcing a major marketing, deal was less than the avg. daily volume. I would expect that CLGY will get more institutional interest over the next couple of months. There's money in the till and three late stage NDAs in the pipeline. I think that the gap in today's chart present a good buying opportunity on gap refill. Patience may be necessary as GKM has reiterated their rating and raised their price target. Gap fill or not, I have a short term target of mid 6s and over the next three months it could be a teen ager, if Tostrex gets a favorable FDA nod in April. ---------------------------------------------------------- I thanked Crossy publicly and sent Ed a PM thanking him for his participation on this thread, so I want to take this opportunity to thank everyone for their contributions. Much appreciation for the insight and varying perspective and honesty that is being offered here by each individual. I wish you all another successful year.